Ribon Therapeutics, Inc. announced it raised $25.2 Million in an initial filing from an offering of $60.2 Million
Ribon Therapeutics, Inc. announced it raised $25.2 Million in an initial filing from an offering of $60.2 Million
06/14/21, 3:49 PM
Location
cambridgeMoney raised
$25.2 million
Company Info
Location
cambridgepark drive
cambridge, maryland, united states
Additional Info
Ribon is a clinical-stage biotechnology company dedicated to the discovery and development of first-in-class small molecule inhibitors to block the fundamental ability of cancer cells to survive under stress.